New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research
Boston, MA -- (SBWIRE) -- 12/21/2012 -- Global Market Direct's pharmaceuticals report, "AbGenomics International, Inc. - Product Pipeline Review - 2012" provides data on the AbGenomics International, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, AbGenomics International, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from AbGenomics International, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.
- AbGenomics International, Inc. - Brief AbGenomics International, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of AbGenomics International, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of AbGenomics International, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the AbGenomics International, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
View Full Report Details and Table of Contents
Reasons to Get this Report
- Evaluate AbGenomics International, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of AbGenomics International, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the AbGenomics International, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with AbGenomics International, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of AbGenomics International, Inc. and identify potential opportunities in those areas.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Baxter International Inc. - Product Pipeline Review - 2012
- Chelsea Therapeutics International Ltd. - Product Pipeline Review - 2012
- Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - 2012
- Takeda Pharmaceuticals International GmbH - Product Pipeline Review - 2012
- BioDelivery Sciences International, Inc. - Product Pipeline Review - 2012
- BTG plc - Product Pipeline Review - 2012
- Bharat Biotech International Limited - Product Pipeline Review - 2012
- Mundipharma International Limited - Product Pipeline Review - 2012
- Gene Signal International SA. - Product Pipeline Review - 2012
- Apitope International NV - Product Pipeline Review - 2012